Spectral AI Seeks FDA Approval for Innovative Burn Assessment Tool

Reported about 11 hours ago

Spectral AI, Inc. (NASDAQ:MDAI) has submitted a De Novo 510k application to the FDA for its DeepView System, an AI-powered, non-invasive diagnostic tool designed to assess burn wounds and predict healing. Intended for emergency departments and burn centers, the system facilitates rapid injury assessments, aiding in treatment decisions. The company, supported by federal funding and multiple contracts, aims to enhance patient outcomes with its groundbreaking technology.

Source: YAHOO

View details

You may also interested in these wikis

Back to all Wikis